<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00596973</url>
  </required_header>
  <id_info>
    <org_study_id>AS07007</org_study_id>
    <nct_id>NCT00596973</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients</brief_title>
  <official_title>Phase IV Study of Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the short term success and feasibility of ileal&#xD;
      transposition with sleeve gastrectomy in non-morbidly obese patients with poorly controlled&#xD;
      Type 2 Diabetes Mellitus&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Business Reasons&#xD;
  </why_stopped>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment sucess based on patients' glycemic control</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Ileal transposition with SG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure: Surgical Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical Treatment</intervention_name>
    <description>Ileal transposition with sleeve gastrectomy</description>
    <arm_group_label>Ileal transposition with SG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed Type 2 Diabetes for 3 to 5 years.&#xD;
&#xD;
          2. Poorly controlled blood sugar despite standard of care* as demonstrated by HbA1c 8-11&#xD;
             for at least 6 months and 3 office visits. Standard of care is based on the ADA&#xD;
             (American Diabetes Association) guidelines which include nutrition, exercise,&#xD;
             education, behavior modification and pharmacological treatment. A co-investigator&#xD;
             endocrinologist will ensure that the above standard of care has been met.&#xD;
&#xD;
          3. BMI between 25.0 and 34.4.&#xD;
&#xD;
          4. Stable weight as determined by no more than a 3% change in body weight in the last 3&#xD;
             months.&#xD;
&#xD;
          5. Age between 35 and 65 (both men and women will be included).&#xD;
&#xD;
          6. Able to provide Informed Consent.&#xD;
&#xD;
          7. Able to comply with follow-up procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous history of major abdominal surgery which may lead to a hostile abdomen.&#xD;
&#xD;
          2. Pregnancy&#xD;
&#xD;
          3. Patients who have an incurable malignant or debilitating disease&#xD;
&#xD;
          4. Serious uncorrectable impairment of coagulation (INR&gt;1.4, PTT &gt; + 3 secs), lungs,&#xD;
             kidney or heart&#xD;
&#xD;
          5. Diagnosed severe eating disorder&#xD;
&#xD;
          6. Use of medication for weight loss in the last 6 months&#xD;
&#xD;
          7. Untreated endocrine disorder&#xD;
&#xD;
          8. Active peptic ulcer&#xD;
&#xD;
          9. Untreated H. pylori&#xD;
&#xD;
         10. Cognitive Impairment&#xD;
&#xD;
         11. Diabetic autonomic neuropathy&#xD;
&#xD;
         12. Symptomatic gastroparesis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barry Salky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>November 28, 2007</study_first_submitted>
  <study_first_submitted_qc>January 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2008</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

